Advertisement
Screener

Myovant Sciences Ltd. Increase (Decrease) in Inventories

Myovant Sciences Ltd. Increase (Decrease) in Inventories

Myovant Sciences Ltd. reported Increase (Decrease) in Inventories of $21.79 million for the 9-month period ending 2022-12-31, per its 10-Q filed 2023-01-26.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2023-01-26

  • Myovant Sciences Ltd. increase (decrease) in inventories for the quarter ending 2022-12-31 was $6.81M, a 1042.62% increase year-over-year.
  • Myovant Sciences Ltd. increase (decrease) in inventories for the quarter ending 2022-09-30 was $1.64M, a 16.66% decline year-over-year.
  • Myovant Sciences Ltd. increase (decrease) in inventories for the quarter ending 2022-06-30 was $13.34M, a 754.77% increase year-over-year.
  • Myovant Sciences Ltd. increase (decrease) in inventories for the quarter ending 2022-03-31 was $847.00K, a 67.56% decline year-over-year.
  • Myovant Sciences Ltd. increase (decrease) in inventories for fiscal 2022 was $4.97M, a 90.46% increase from fiscal 2021.
  • Myovant Sciences Ltd. increase (decrease) in inventories for fiscal 2021 was $2.61M.
  • Myovant Sciences Ltd. increase (decrease) in inventories for fiscal 2020 was $0.00.
  • Myovant Sciences Ltd. increase (decrease) in inventories for fiscal 2019 was $0.00.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 12 month
2022-12-31$6.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-26
$8.45M
derived: sum of 2 quarters · filed 2023-01-26
$21.79M
10-Q · filed 2023-01-26
$22.64M
derived: sum of 4 quarters · filed 2023-01-26
2022-09-30$1.64M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-26
$14.98M
10-Q · filed 2022-10-26
$15.83M
derived: sum of 3 quarters · filed 2022-10-26
$16.43M
derived: sum of 4 quarters · filed 2023-01-26
2022-06-30$13.34M
10-Q · filed 2022-07-27
$14.19M
derived: sum of 2 quarters · filed 2022-07-27
$14.79M
derived: sum of 3 quarters · filed 2023-01-26
$16.75M
derived: sum of 4 quarters · filed 2023-01-26
2022-03-31$847.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11
$1.44M
derived: sum of 2 quarters · filed 2023-01-26
$3.41M
derived: sum of 3 quarters · filed 2023-01-26
$4.97M
10-K · filed 2022-05-11
2021-12-31$596.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-01-26
$2.56M
derived: sum of 2 quarters · filed 2023-01-26
$4.13M
10-Q · filed 2023-01-26
$6.74M
derived: sum of 4 quarters · filed 2023-01-26
2021-09-30$1.97M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-10-26
$3.53M
10-Q · filed 2022-10-26
$6.14M
derived: sum of 3 quarters · filed 2022-10-26
$6.14M
derived: sum of 4 quarters · filed 2022-10-26
2021-06-30$1.56M
10-Q · filed 2022-07-27
$4.17M
derived: sum of 2 quarters · filed 2022-07-27
$4.17M
derived: sum of 3 quarters · filed 2022-07-27
$4.17M
derived: sum of 4 quarters · filed 2022-07-27
2021-03-31$2.61M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-11
$2.61M
derived: sum of 2 quarters · filed 2022-05-11
$2.61M
derived: sum of 3 quarters · filed 2022-05-11
$2.61M
10-K · filed 2022-05-11
2020-12-31$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-01-26
$0.00
derived: sum of 2 quarters · filed 2022-01-26
$0.00
10-Q · filed 2022-01-26
2020-09-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-10-26
$0.00
10-Q · filed 2021-10-26
2020-06-30$0.00
10-Q · filed 2021-07-28
2020-03-31$0.00
10-K · filed 2022-05-11
2019-03-31$0.00
10-K · filed 2021-05-11